
By-health Co.,Ltd.
By-health Co., Ltd. is China's leading dietary supplements company, publicly traded on the Shenzhen Stock Exchange and headquartered in Zhuhai, Guangdong. With five production bases in China and an annual capacity of 5 billion supplement tablets/capsules, the company achieved RMB 8.5 billion (approximately $1.2 billion) in revenue in 2024. By-health maintains its dominant market position through comprehensive product portfolios, stringent quality control, and extensive distribution networks across China.
Strengths: By-health's core strengths are its absolute leadership in China's dietary supplement market with the top brand position, comprehensive multi-channel distribution network covering pharmacies and e-commerce platforms, and stringent quality control system with pharmaceutical-grade production standards.
Weaknesses: The company faces challenges including heavy reliance on the domestic market (95% of revenue) with limited international presence, intensifying competition in China's dietary supplement sector, and vulnerability to raw material cost fluctuations.Read MoreShow Less
Strengths: By-health's core strengths are its absolute leadership in China's dietary supplement market with the top brand position, comprehensive multi-channel distribution network covering pharmacies and e-commerce platforms, and stringent quality control system with pharmaceutical-grade production standards.
Weaknesses: The company faces challenges including heavy reliance on the domestic market (95% of revenue) with limited international presence, intensifying competition in China's dietary supplement sector, and vulnerability to raw material cost fluctuations.
Listed market data
300146 · SZSE · weeklyHistory →- Market cap
- $2.5 B
- Share price
- CNY 10.39
- 1Y change
- -18.1%
- Recent change
- +1.1%
- IPO price
- +59.0%
11-02 → 11-03
CNY 110.00 · from 2010-12-15
Financial history
Full market history- 2026-11CNY 10.39$2.5 B+4.8%
- 2026-10CNY 9.91$2.4 B+5.1%
- 2026-09CNY 9.43$2.2 B-3.8%
- 2026-08CNY 9.80$2.3 B-6.1%
- 2026-07CNY 10.44$2.5 B+15.5%
- 2026-06CNY 9.04$2.2 B-7.5%
- 2026-05CNY 9.77$2.3 B-7.0%
- 2026-04CNY 10.50$2.5 B-4.4%
- 2026-03CNY 10.98$2.6 B-9.0%
- 2026-02CNY 12.06$2.9 B-0.9%
- 2026-01CNY 12.17$2.9 B+1.3%
- 2025-12CNY 12.01$2.9 B—
Ownership & Control
Latest available filings- Controlling entity
- Publicly held — no controlling shareholder disclosed
- Company type
- Brand & Manufacturer
- Insiders
- 49.59%
- Institutions
- 5.60%(97 holders)
- Free float
- 11.11%
Percentages are of total shares outstanding, aggregated from 13F-style filings via Yahoo Finance. Institutional figures reflect US-filed positions and may undercount owners filing elsewhere. No figure is shown where none is disclosed.
In the press
All coverage →5 latest headlines4- By-health Co., Ltd. Class A Estimates – SZSE:300146 - TradingViewwww.tradingview.com2026-10-24
- Byhealth: Revenue growth continued, but 9M earnings and operating cash flow weakened - TradingViewwww.tradingview.com2026-10-23
- Byhealth: Revenue up 3.94% but net profit down 18.11% amid rising costs and digital investment - TradingViewwww.tradingview.com2026-08-07
- Byhealth: Revenue and net profit fell sharply in Q1 2025 amid weak sales across all major brands and channels - TradingViewwww.tradingview.com2025-04-26
- Byhealth: 2024 saw a 62.6% net profit drop amid industry headwinds, with a focus on innovation for 2025 - TradingViewwww.tradingview.com2025-03-22
Quick Facts
Headquarters
Zhuhai, Guangdong, China
Founded
2005
Employees
5K+
Market cap
$2.5 B
Presence
21+ Countries
Listing
SZSE: SZCategories
18 categories · scroll for more
Related
Similar listed companies
- Eli Lilly and Company· $1.1 T
- Johnson & Johnson (J&J)· $658 B
- Allergan Aesthetics· $521 B
- AbbVie Inc.· $521 B
- The Coca-Cola Company· $405 B
- F. Hoffmann-La Roche AG· $381 B
Data Sources & Methodology
This corporate profile is compiled from publicly available sources including company annual reports, SEC/regulatory filings, official press releases, and verified third-party industry databases. Financial figures reflect the most recent fiscal year disclosures and are cross-validated across multiple independent references.
VerityRank Score is calculated using a proprietary multi-dimensional model evaluating market presence, financial strength, operational scale, innovation capacity, and brand influence. Individual dimension scores are normalized against industry peers and updated quarterly.
Disclaimer: This profile is for informational purposes only. VerityRank makes no warranties regarding completeness or timeliness. This content does not constitute investment advice or endorsement.
Key references: SZSE:300146
